Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:APOP

Cellect Biotechnology (APOP) Stock Price, News & Analysis

Cellect Biotechnology logo

About Cellect Biotechnology Stock (NASDAQ:APOP)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
$7.54
$13.40
52-Week Range
N/A
Volume
17,400 shs
Average Volume
479,845 shs
Market Capitalization
$12.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.

Remove Ads
Receive APOP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellect Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

APOP Stock News Headlines

DOGE could send 6 AI stocks through the roof
Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement from Elon any day now … Thousands of government jobs could be replaced … By a new form of AI. Recently perfected by Musk and his team at xAI.
Krystal Biotech Inc.
Raleigh/Durham Biotech News
See More Headlines

APOP Stock Analysis - Frequently Asked Questions

Cellect Biotechnology Ltd. (NASDAQ:APOP) posted its earnings results on Tuesday, November, 13th. The company reported ($0.58) earnings per share for the quarter, missing analysts' consensus estimates of ($0.56) by $0.02.

Shares of Cellect Biotechnology split on Tuesday, October 26th 2021. The 2-1 split was announced on Tuesday, October 26th 2021. The newly minted shares were distributed to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Protalix BioTherapeutics (PLX), Advanced Micro Devices (AMD), NVIDIA (NVDA), Acasti Pharma (ACST) and Corbus Pharmaceuticals (CRBP).

Company Calendar

Last Earnings
11/13/2018
Today
3/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:APOP
Employees
2,020
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$4.77 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$12.87 million
Optionable
Not Optionable
Beta
1.87

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:APOP) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners